Abstract
Purpose of Review
This paper aims to give the specialist and non-specialist alike an overview of the considerations involved in the management of cancer-related pain in the older population.
Recent Findings
Comprehensive guidelines on cancer pain management have been published recently by expert bodies. Cancer pain differs in many respects to other pain conditions and we are likely to encounter it more frequently in older patients in the future. The elderly are more sensitive to the effects of many analgesic medications.
Summary
The elderly patient with cancer pain presents a unique challenge to the treating physician. The biological effects of ageing impact on the efficacy of many pain management strategies as well as its diagnosis and assessment. Treatment options can be broadly divided into pharmacological, non-pharmacological and interventional. A multidisciplinary approach and frequent re-assessment are essential in achieving favourable outcomes in this patient group.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Sander M, Oxlund B, Jespersen A, Krasnik A, Mortensen EL, Westendorp RGJ, et al. The challenges of human population ageing. Age Ageing. 2014;44(2):185–7. https://doi.org/10.1093/ageing/afu189.
Marosi C, Köller M. Challenge of cancer in the elderly. ESMO Open. 2016;1(3):e000020. https://doi.org/10.1136/esmoopen-2015-000020.
Bluethmann SM, Mariotto AB, Rowland JH. Anticipating the “Silver tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. AACR; 2016.
Pallis AG, Fortpied C, Wedding U, Van Nes MC, Penninckx B, Ring A, et al. EORTC elderly task force position paper: approach to the older cancer patient. Eur J Cancer. 2010;46(9):1502–13. https://doi.org/10.1016/j.ejca.2010.02.022.
Yancik R. Cancer burden in the aged: an epidemiologic and demographic overview. Cancer: Interdisciplinary International Journal of the American Cancer Society. 1997;80(7):1273–83.
van den Beuken–van Everdingen MHJ, LMJ H, Joosten EAJ, Tjan-Heijnen VCG, Janssen DJA. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manag. 2016;51(6):1070–90.e9. https://doi.org/10.1016/j.jpainsymman.2015.12.340.
Burton AW, Fanciullo GJ, Beasley RD, Fisch MJ. Chronic pain in the cancer survivor: a new frontier. Pain Med. 2007;8(2):189–98.
Brochet B, Michel P, Barberger-Gateau P, J-F DARTIGUES. Population-based study of pain in elderly people: a descriptive survey. Age Ageing. 1998;27(3):279–84.
Urban D, Cherny N, Catane R. The management of cancer pain in the elderly. Crit Rev Oncol Hematol. 2010;73(2):176–83. https://doi.org/10.1016/j.critrevonc.2009.03.008.
• Brunello A, Ahcene-Djaballah S, Lettiero A, Tierno G, Fiduccia P, Guglieri I et al. Prevalence of pain in patients with cancer aged 70 years or older: a prospective observational study. J Geriatr Oncol. 2019. A total of 745 patients were enrolled in this study. Approximately one third of patients with cancer reported pain by means of a questionnaire and use of a numerical rating scale. Pain was detected by an Oncologist in 20.4% of cases and deemed non-cancer related in 46.2%. There was minimal correlation between patients reported pain intensity and that evaluated by a physician.
Bernabei R, Gambassi G, Lapane K, Landi F, Gatsonis C, Dunlop R, et al. Management of pain in elderly patients with cancer. Jama. 1998;279(23):1877–82.
Greco MT, Roberto A, Corli O, Deandrea S, Bandieri E, Cavuto S, et al. Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. J Clin Oncol. 2014;32(36):4149–54.
Cleeland CS. Undertreatment of cancer pain in elderly patients. Jama. 1998;279(23):1914–5.
Kaye AD, Baluch A, Scott JT. Pain management in the elderly population: a review. Ochsner J. 2010;10(3):179–87.
Herr K, Coyne PJ, McCaffery M, Manworren R, Merkel S. Pain assessment in the patient unable to self-report: position statement with clinical practice recommendations. Pain Manag Nurs. 2011;12(4):230–50.
Pesonen A, Kauppila T, Tarkkila P, Sutela A, Niinistö L, Rosenberg P. Evaluation of easily applicable pain measurement tools for the assessment of pain in demented patients. Acta Anaesthesiol Scand. 2009;53(5):657–64.
Yeager KA, Miaskowski C, Dibble SL, Wallhagen M, editors. Differences in pain knowledge and perception of the pain experience between outpatients with cancer and their family caregivers. Oncol Nurs Forum; 1995.
Weiner D, Peterson B, Keefe F. Chronic pain-associated behaviors in the nursing home: resident versus caregiver perceptions. Pain. 1999;80(3):577–88.
Tracy B, Sean MR. Pain management in older adults. Clin Ther. 2013;35(11):1659–68. https://doi.org/10.1016/j.clinthera.2013.09.026.
Ruoff GE. Depression in the patient with chronic pain. J Fam Pract. 1996;43(6):S25–S.
• Schwei MJ, Honore P, Rogers SD, Salak-Johnson JL, Finke MP, Ramnaraine ML, et al. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci. 1999;19(24):10886–97 Describes the first animal model of cancer pain, showing a correlation between damage to surrounding tissue by an invading tumour mass and subsequent adaption of the central nervous system to a painful stimulus.
Mantyh PW, Clohisy DR, Koltzenburg M, Hunt SP. Molecular mechanisms of cancer pain. Nat Rev Cancer. 2002;2(3):201–9. https://doi.org/10.1038/nrc747.
DeLeo JA, Yezierski RP. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain. 2001;90(1):1–6.
Opree A, Kress M. Involvement of the proinflammatory cytokines tumor necrosis factor-α, IL-1β, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin. J Neurosci. 2000;20(16):6289–93.
Stoscheck CM, King LE. Role of epidermal growth factor in carcinogenesis. Cancer Res. 1986;46(3):1030–7.
Roman C, Saha D, Beauchamp RD. TGF-β and colorectal carcinogenesis. Microsc Res Tech. 2001;52(4):450–7.
Silver B. Platelet-derived growth factor in human malignancy. BioFactors (Oxford, England). 1992;3(4):217–27.
Engin K, Leeper D, Cater J, Thistlethwaite A, Tupchong L, McFarlane J. Extracellular pH distribution in human tumours. Int J Hyperth. 1995;11(2):211–6.
Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron. 1998;21(3):531–43.
Bassilana F, Champigny G, Waldmann R, de Weille JR, Heurteaux C, Lazdunski M. The acid-sensitive ionic channel subunit ASIC and the mammalian degenerin MDEG form a heteromultimeric H+-gated Na+ channel with novel properties. J Biol Chem. 1997;272(46):28819–22.
Clohisy DR, Perkins SL, Ramnaraine ML. Review of cellular mechanisms of tumor osteolysis. Clin Orthop Relat Res (1976–2007). 2000;373:104–14.
Clohisy DR, Mantyh PW. Bone cancer pain. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2003;97(S3):866–73.
Honore P, Rogers S, Schwei M, Salak-Johnson J, Luger N, Sabino M, et al. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience. 2000;98(3):585–98.
Nauta HJ, Soukup VM, Fabian RH, Lin JT, Grady JJ, Williams CG, et al. Punctate midline myelotomy for the relief of visceral cancer pain. J Neurosurg Spine. 2000;92(2):125–30.
Willis WD, Al-Chaer ED, Quast MJ, Westlund KN. A visceral pain pathway in the dorsal column of the spinal cord. Proc Natl Acad Sci. 1999;96(14):7675–9.
Bannister K, Bee LA, Dickenson AH. Preclinical and early clinical investigations related to monoaminergic pain modulation. Neurotherapeutics. 2009;6(4):703–12.
Boakye PA, Olechowski C, Rashiq S, Verrier MJ, Kerr B, Witmans M, et al. A critical review of neurobiological factors involved in the interactions between chronic pain, depression, and sleep disruption. Clin J Pain. 2016;32(4):327–36.
Polomano RC, Bennett GJ. Chemotherapy-evoked painful peripheral neuropathy. Pain Med. 2001;2(1):8–14.
Cheng KKF, Lee DTF. Effects of pain, fatigue, insomnia, and mood disturbance on functional status and quality of life of elderly patients with cancer. Crit Rev Oncol Hematol. 2011;78(2):127–37. https://doi.org/10.1016/j.critrevonc.2010.03.002.
Bennett MI, Laird B, van Litsenburg C, Nimour M. Pregabalin for the management of neuropathic pain in adults with cancer: a systematic review of the literature. Pain Med. 2013;14(11):1681–8. https://doi.org/10.1111/pme.12212.
Te Boveldt N, Vernooij-Dassen M, Burger N, Ijsseldijk M, Vissers K, Engels Y. Pain and its interference with daily activities in medical oncology outpatients. Pain Physician. 2013;16(4):379–89.
Kua J. The prevalence of psychological and psychiatric sequelae of cancer in the elderly-how much do we know. Ann Acad Med Singap. 2005;34(3):250–6.
Richardson JL, Marks G, Levine A. The influence of symptoms of disease and side effects of treatment on compliance with cancer therapy. J Clin Oncol. 1988;6(11):1746–52. https://doi.org/10.1200/jco.1988.6.11.1746.
Miaskowski C, Kragness L, Dibble S, Wallhagen M. Differences in mood states, health status, and caregiver strain between family caregivers of oncology outpatients with and without cancer-related pain. J Pain Symptom Manag. 1997;13(3):138–47. https://doi.org/10.1016/S0885-3924(96)00297-7.
Cohen HJ. Cancer and the functional status of the elderly. Cancer: Interdisciplinary International Journal of the American Cancer Society. 1997;80(10):1883–6.
Fortner BV, Okon TA, Portenoy RK. A survey of pain-related hospitalizations, emergency department visits, and physician office visits reported by cancer patients with and without history of breakthrough pain. J Pain. 2002;3(1):38–44.
Bernfort L, Gerdle B, Rahmqvist M, Husberg M, Levin L-Å. Severity of chronic pain in an elderly population in Sweden—impact on costs and quality of life. Pain. 2015;156(3):521–7.
Carlson CL. Effectiveness of the World Health Organization cancer pain relief guidelines: an integrative review. J Pain Res. 2016;9:515.
Abernethy A, Samsa G, Matchar D. A clinical decision and economic analysis model of cancer pain management. Cancer. 2003:651–64.
Page GG, Blakely WP, Ben-Eliyahu S. Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain. 2001;90(1–2):191–9.
Sacerdote P, Manfredi B, Bianchi M, Panerai AE. Intermittent but not continuous inescapable footshock stress affects immune responses and immunocyte beta-endorphin concentrations in the rat. Brain Behav Immun. 1994;8(3):251–60. https://doi.org/10.1006/brbi.1994.1023.
Neeman E, Ben-Eliyahu S. Surgery and stress promote cancer metastasis: new outlooks on perioperative mediating mechanisms and immune involvement. Brain Behav Immun. 2013;30:S32–40.
Hooijmans CR, Geessink FJ, Ritskes-Hoitinga M, Scheffer G-J. A systematic review and meta-analysis of the ability of analgesic drugs to reduce metastasis in experimental cancer models. Pain. 2015;156(10):1835.
Spanjer MRK, Bakker NA, Absalom AR. Pharmacology in the elderly and newer anaesthesia drugs. Best Pract Res Clin Anaesthesiol. 2011;25(3):355–65.
Coldrey JC, Upton RN, Macintyre PE. Advances in analgesia in the older patient. Best Pract Res Clin Anaesthesiol. 2011;25(3):367–78.
•• Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, et al. Management of cancer pain in adult patients: ESMO clinical practice guidelines†. Ann Oncol. 2018;29(Supplement_4):iv166–iv91. https://doi.org/10.1093/annonc/mdy152 This comprehensive and current clinical guideline is based on best available evidence for both the assessment and management of cancer pain.
Wiffen PJ, Derry S, Moore RA, McNicol ED, Bell RF, Carr DB, et al. Oral paracetamol (acetaminophen) for cancer pain. Cochrane Database Syst Rev. 2017;7.
McCarberg BH. NSAIDs in the older patient: balancing benefits and harms. Pain Med. 2013;14(suppl_1):S43–S4. https://doi.org/10.1111/pme.12253.
Derry S, Wiffen PJ, Moore RA, McNicol ED, Bell RF, Carr DB et al. Oral nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer pain in adults. Cochrane Database Syst Rev 2017(7).
• Gupta D, Avram MJ. Rational opioid dosing in the elderly: dose and dosing interval when initiating opioid therapy. Clin Pharmacol Ther. 2012;91(2):339–43 This important paper highlights the caution required when initiating and titrating opioids in older patients.
Ballantyne JC, Kalso E, Stannard C. WHO analgesic ladder: a good concept gone astray. British Medical Journal Publishing Group; 2016.
Al-Tawil N, Odar-Cederlöf I, Berggren A-C, Johnson HE, Persson J. Pharmacokinetics of transdermal buprenorphine patch in the elderly. Eur J Clin Pharmacol. 2013;69(2):143–9.
Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012;13(2):e58–68.
Enting RH, Oldenmenger WH, Van der Rijt CC, Wilms EB, Elfrink EJ, Elswijk I, et al. A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2002;94(11):3049–56.
Glue P, Cape G, Tunnicliff D, Lockhart M, Lam F, Gray A, et al. Switching opioid-dependent patients from methadone to morphine: safety, tolerability, and methadone pharmacokinetics. J Clin Pharmacol. 2016;56(8):960–5.
Fallon M. Neuropathic pain in cancer. Br J Anaesth. 2013;111(1):105–11.
Pickering G. Antiepileptics for post-herpetic neuralgia in the elderly: current and future prospects. Drugs Aging. 2014;31(9):653–60.
Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17(9):1113–e88.
Fallon MT, Wilcock A, Kelly CA, Paul J, Lewsley L-A, Norrie J, et al. Oral ketamine vs placebo in patients with cancer-related neuropathic pain: a randomized clinical TrialOral ketamine vs placebo in patients with cancer-related neuropathic painletters. JAMA Oncol. 2018;4(6):870–2. https://doi.org/10.1001/jamaoncol.2018.0131.
Bell RFF, Eccleston C, Kalso EA. Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev 2017(6).
De la Cruz M, Ransing V, Yennu S, Wu J, Liu D, Reddy A, et al. The frequency, characteristics, and outcomes among cancer patients with delirium admitted to an acute palliative care unit. Oncologist. 2015;20(12):1425–31.
Şenel G, Uysal N, Oguz G, Kaya M, Kadioullari N, Koçak N, et al. Delirium frequency and risk factors among patients with cancer in palliative care unit. Am J Hosp Palliat Care®. 2017;34(3):282–6.
Bennett MI, Bagnall A-M, Closs SJ. How effective are patient-based educational interventions in the management of cancer pain? Systematic review and meta-analysis. PAIN®. 2009;143(3):192–9.
Gorin SS, Krebs P, Badr H, Janke EA, Jim HS, Spring B, et al. Meta-analysis of psychosocial interventions to reduce pain in patients with cancer. J Clin Oncol. 2012;30(5):539–47.
Loh J, Gulati A. The use of transcutaneous electrical nerve stimulation (TENS) in a major cancer center for the treatment of severe cancer-related pain and associated disability. Pain Med. 2015;16(6):1204–10.
Lu W, Rosenthal DS. Acupuncture for cancer pain and related symptoms. Curr Pain Headache Rep. 2013;17(3):321.
Hu C, Zhang H, Wu W, Yu W, Li Y, Bai J, et al. Acupuncture for pain management in cancer: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2016;2016.
Syrjala KL, Jensen MP, Mendoza ME, Yi JC, Fisher HM, Keefe FJ. Psychological and behavioral approaches to cancer pain management. J Clin Oncol. 2014;32(16):1703.
Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KA, Grond S. Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain. 2001;93(3):247–57.
Vranken JH, van der Vegt MH, Zuurmond WW, Pijl AJ, Dzoljic M. Continuous brachial plexus block at the cervical level using a posterior approach in the management of neuropathic cancer pain. Reg Anesth Pain Med. 2001;26(6):572–5.
Buchanan D, Brown E, Millar F, Mosgrove F, Bhat R, Levack P. Outpatient continuous interscalene brachial plexus block in cancer-related pain. J Pain Symptom Manag. 2009;38(4):629–34.
Pacenta HL, Kaddoum RN, Pereiras LA, Chidiac EJ, Burgoyne LL. Continuous tunnelled femoral nerve block for palliative care of a patient with metastatic osteosarcoma. Anaesth Intensive Care. 2010;38(3):563–5.
Ilfeld BM. Continuous peripheral nerve blocks: a review of the published evidence. Anesth Analg. 2011;113(4):904–25.
Zhong W, Yu Z, Zeng JX, Lin Y, Yu T, Min XH, et al. Celiac plexus block for treatment of pain associated with pancreatic cancer: a meta-analysis. Pain Pract. 2014;14(1):43–51.
Hou S, Novy D, Felice F, Koyyalagunta D. Efficacy of superior hypogastric plexus neurolysis for the treatment of cancer-related pelvic pain. Pain Med. 2019. https://doi.org/10.1093/pm/pnz151.
Correia JS, Silva M, Castro C, Miranda L, Agrelo A. The efficacy of the ganglion impar block in perineal and pelvic cancer pain. Support Care Cancer 2019:1–4.
Filippiadis DK, Tselikas L, Tsitskari M, Kelekis A, de Baere T, Ryan AG. Percutaneous neurolysis for pain management in oncological patients. Cardiovasc Intervent Radiol. 2019;42(6):791–9.
• Zheng S, He L, Yang X, Li X, Yang Z. Evaluation of intrathecal drug delivery system for intractable pain in advanced malignancies: a prospective cohort study. Medicine. 2017;96(11). A prospective cohort study of 53 patients with either intractable cancer-related pain or suffering intolerable drug-related adverse effects. Recruited patietns were commenced on a intrathecal drug delivery system (IDDS) with a patient-controlled intrathecal analgesia pump. The authors reported a decrease in pain scores and a statistical improvement in quality of life among patients commenced on IDDS therapy.
Sayed D, Monroe F, Orr WN, Phadnis M, Khan TW, Braun E, et al. Retrospective analysis of intrathecal drug delivery: outcomes, efficacy, and risk for cancer-related pain at a high volume academic medical center. Neuromodulation: Technology at the Neural Interface. 2018;21(7):660–4.
Dhanalaksmi KM. Infectious complications related to intrathecal drug delivery system and spinal cord stimulator system implantations at a comprehensive cancer pain center. Pain Physician. 2013;16:251–7.
Peng L, Min S, Zejun Z, Wei K, Bennett MI. Spinal cord stimulation for cancer-related pain in adults. Cochrane Database Syst Rev 2015(6).
Rades D, Abrahm JL. The role of radiotherapy for metastatic epidural spinal cord compression. Nat Rev Clin Oncol. 2010;7(10):590.
Porta-Sales J, Garzón-Rodríguez C, Llorens-Torromé S, Brunelli C, Pigni A, Caraceni A. Evidence on the analgesic role of bisphosphonates and denosumab in the treatment of pain due to bone metastases: a systematic review within the European Association for Palliative Care guidelines project. Palliat Med. 2017;31(1):5–25.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Palliative Medicine
Rights and permissions
About this article
Cite this article
Finnerty, D., O’Gara, Á. & Buggy, D.J. Managing Pain in the Older Cancer Patient. Curr Oncol Rep 21, 100 (2019). https://doi.org/10.1007/s11912-019-0854-7
Published:
DOI: https://doi.org/10.1007/s11912-019-0854-7